Adipo Therapeutics
PrivateLast Round
Series A
May 9, 2025
Total Funding Raised
$6.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Adipo Therapeutics is a biotechnology company developing a novel therapeutic platform that uses Notch-inhibiting nanoparticles to convert energy-storing white fat into energy-burning brown fat for the treatment of obesity and Type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adipo Therapeutics Comparables
Compare Adipo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Equator Therapeutics | 85% | |
| Energesis Pharmaceuticals, Inc. | 83% | |
| Cyta Therapeutics | 81% |
Adipo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 9, 2025 | ||||
| Grant | Jun 24, 2024 | ||||
| Seed | Jan 31, 2024 | ||||
| Seed | Apr 11, 2023 | ||||
| Seed | Jan 11, 2022 | ||||
Grant | Sep 13, 2018 |
Key People
Founding team and executive leadership
Adipo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Purdue Research Foundation | Seed |
| Elevate Ventures | Seed |
| State of Indiana | Grant |
| NIH RADx | Grant |
| VisionTech Partners | Seed |
| Purdue Innovates Ventures | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 51% MoM, reaching 2.2K.
- Jul 28, 2026
Monthly visitors increased 123% MoM, reaching 1.5K.
Adipo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Adipo Therapeutics's valuation, stock price, and market status.
Is Adipo Therapeutics a public or private company?
Adipo Therapeutics is a private company.
What is the current stock price of Adipo Therapeutics?
Adipo Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Adipo Therapeutics worth (valuation)?
Valuation information for Adipo Therapeutics is not publicly available.
Can I buy Adipo Therapeutics stock?
Adipo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Adipo Therapeutics's last funding round?
Adipo Therapeutics's most recent funding round was Seed on January 31, 2024.
Who are the main investors in Adipo Therapeutics?
Key investors in Adipo Therapeutics include Purdue Research Foundation, Elevate Ventures, NIH RADx, VisionTech Partners, IU Ventures.
Will Adipo Therapeutics IPO soon?
No public IPO plans have been announced for Adipo Therapeutics.
How can I track Adipo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Adipo Therapeutics's secondary market activity and sign up for updates.